[引用][C] P-611 Final results from a phase II study of erlotinib (TarcevaTM) monotherapy in patients with advanced non-small cell lung cancer following failure of platinum …
R Perez-Soler, A Chachoua, M Huberman, D Karp… - Lung Cancer, 2003 - infona.pl
P-611 Final results from a phase II study of erlotinib (TarcevaTM) monotherapy in patients with
advanced non-small cell lung cancer following failure of platinum-based chemotherapy × …
advanced non-small cell lung cancer following failure of platinum-based chemotherapy × …